Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cannom

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Heart Rhythm|June 7, 2008
Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decisionRachel Lampert, David Cannom
Progress in Cardiovascular Diseases|March 12, 2013
Introduction: Syncope issueDavid G Benditt, David Cannom
Journal of Cardiovascular Electrophysiology|January 24, 2006
Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society membersRachel Lampert, David Cannom, Brian Olshansky
Heart Rhythm|January 9, 2017
Discrepancies in the U.S. and European guidelines involving the implantable cardioverter-defibrillator and cardiac resynchronization therapy: Need for a single shared international publicationValentina Kutyifa, David Cannom, Helmut U Klein, et al.
Critical Pathways in Cardiology|June 4, 2009
Sudden cardiac arrest prevention pathways and toolsGregg C Fonarow, Nancy M Albert, David Cannom, et al.
Heart Rhythm O2|July 30, 2025
Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports RegistryMerije T Chukumerije, Brian Olshansky, Elizabeth V Saarel, et al.
Journal of Cardiovascular Electrophysiology|December 21, 2012
QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRTAndrew Brenyo, Mohan Rao, Alon Barsheshet, et al.
Pacing and Clinical Electrophysiology : PACE|July 26, 2002
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leadsRobert G Hauser, David Cannom, David L Hayes, et al.
Progress in Cardiovascular Diseases|March 31, 2020
Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessmentBrian Olshansky, David Cannom, Artur Fedorowski, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 16, 2016
Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney diseaseUsama A Daimee, Yitschak Biton, Arthur J Moss, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Heart Rhythm|June 7, 2008
Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decisionRachel Lampert, David Cannom
Progress in Cardiovascular Diseases|March 12, 2013
Introduction: Syncope issueDavid G Benditt, David Cannom
Journal of Cardiovascular Electrophysiology|January 24, 2006
Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society membersRachel Lampert, David Cannom, Brian Olshansky
Heart Rhythm|January 9, 2017
Discrepancies in the U.S. and European guidelines involving the implantable cardioverter-defibrillator and cardiac resynchronization therapy: Need for a single shared international publicationValentina Kutyifa, David Cannom, Helmut U Klein, et al.
Critical Pathways in Cardiology|June 4, 2009
Sudden cardiac arrest prevention pathways and toolsGregg C Fonarow, Nancy M Albert, David Cannom, et al.
Heart Rhythm O2|July 30, 2025
Case series of black athletes participating in sports with an implantable cardioverter-defibrillator: Data from the ICD Sports RegistryMerije T Chukumerije, Brian Olshansky, Elizabeth V Saarel, et al.
Journal of Cardiovascular Electrophysiology|December 21, 2012
QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRTAndrew Brenyo, Mohan Rao, Alon Barsheshet, et al.
Pacing and Clinical Electrophysiology : PACE|July 26, 2002
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leadsRobert G Hauser, David Cannom, David L Hayes, et al.
Progress in Cardiovascular Diseases|March 31, 2020
Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessmentBrian Olshansky, David Cannom, Artur Fedorowski, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|September 16, 2016
Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney diseaseUsama A Daimee, Yitschak Biton, Arthur J Moss, et al.
Pageof 3